J Clin Gynecol Obstet

Journal of Clinical Gynecology and Obstetrics, ISSN 1927-1271 print, 1927-128X online, Open Access

Article copyright, the authors; Journal compilation copyright, J Clin Gynecol Obstet and Elmer Press Inc

Journal website http://www.jcgo.org

Original Article

Volume 1, Number 4-5, October 2012, pages 67-70

The Prognostic Value of Tubal Patency Test After Medical Treatment of an Ectopic Pregnancy

Tables

**Table 1.** Single Dose Methotrexate Protocol for the Treatment of Ectopic Pregnancy
Day	Test	Therapy or procedure
beta-hCG, beta human chorionic gonadotrophin; CBC, complete blood count; AST, aspartate aminotransferase; BUN, blood urea nitrogen; MTX, methotrexate.
1	beta-hCG, CBC, blood type and screen AST, BUN, creatinine	MTX 50 mg/m² IM
4	beta-hCG
7	beta-hCG	Repeat MTX if day 7 hCG < 15% lower than day 4 hCG

**Table 2.** The Ipsilateral and Contralateral Tube Patency Following Methotrexate Treatment and Salpingectomy
Hystsalpingography	Ipsilateral tube Obstruction Patency	Contralateral tube Obstruction Patency	Total
MTX	5 (16.7%), 25 (83.3%)	2 (6.7%), 28 (93.3%)	30
salpingectomy	-	7 (17.5%), 33 (82.5%)	40